{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:29:17Z","timestamp":1778700557094,"version":"3.51.4"},"reference-count":205,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC0900905"],"award-info":[{"award-number":["2016YFC0900905"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["81873488"],"award-info":[{"award-number":["81873488"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["82060069"],"award-info":[{"award-number":["82060069"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide and results in a significantly increased ischemic stroke (IS) risk. IS risk stratification tools are widely being applied to guide anticoagulation treatment decisions and duration in patients with non-valvular AF (NVAF). The CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score is largely validated and currently recommended by renowned guidelines. However, this score is heavily dependent on age, sex, and comorbidities, and exhibits only moderate predictive power. Finding effective and validated clinical biomarkers to assist in personalized IS risk evaluation has become one of the promising directions in the prevention and treatment of NVAF. A number of studies in recent years have explored differentially expressed biomarkers in NVAF patients with and without IS, and the potential role of various biomarkers for prediction or early diagnosis of IS in patients with NVAF. In this review, we describe the clinical application and utility of AF characteristics, cardiac imaging and electrocardiogram markers, arterial stiffness and atherosclerosis-related markers, circulating biomarkers, and novel genetic markers in IS diagnosis and management of patients with NVAF. We conclude that at present, there is no consensus understanding of a desirable biomarker for IS risk stratification in NVAF, and enrolling these biomarkers into extant models also remains challenging. Further prospective cohorts and trials are needed to integrate various clinical risk factors and biomarkers to optimize IS prediction in patients with NVAF. However, we believe that the growing insight into molecular mechanisms and in-depth understanding of existing and emerging biomarkers may further improve the IS risk identification and guide anticoagulation therapy in patients with NVAF.<\/jats:p>","DOI":"10.3389\/fcvm.2021.682538","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T16:11:32Z","timestamp":1625155892000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation"],"prefix":"10.3389","volume":"8","author":[{"given":"Luxiang","family":"Shang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yankai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakun","family":"Bo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baopeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrcardio.2014.118","article-title":"Global epidemiology of atrial fibrillation","volume":"11","author":"Rahman","year":"2014","journal-title":"Nat Rev Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e006350","DOI":"10.1161\/CIRCEP.118.006350","article-title":"Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (Atherosclerosis Risk in Communities)","volume":"11","author":"Mou","year":"2018","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1161\/CIRCULATIONAHA.117.031431","article-title":"Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial Fibrillation","volume":"137","author":"Weng","year":"2018","journal-title":"Circulation."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: epidemiology, pathophysiology, clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and stroke statistics-2016 update: a report from the american heart association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ccl.2015.12.002","article-title":"The epidemiology of atrial fibrillation and stroke","volume":"34","author":"Pistoia","year":"2016","journal-title":"Cardiol Clin."},{"key":"B7","doi-asserted-by":"publisher","first-page":"j5058","DOI":"10.1136\/bmj.j5058","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"L\u00f3pez-L\u00f3pez","year":"2017","journal-title":"BMJ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.joa.2017.05.004","article-title":"2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation","volume":"33","author":"Chiang","year":"2017","journal-title":"J Arrhythm."},{"key":"B9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines and the heart rhythm society","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"27410","DOI":"10.1038\/srep27410","article-title":"Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: a nationwide cohort study","volume":"6","author":"Nielsen","year":"2016","journal-title":"Sci Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review","volume":"118","author":"Borre","year":"2018","journal-title":"Thromb Haemost."},{"key":"B13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/10408363.2018.1525335","article-title":"Novel biomarkers of cardiovascular disease: applications in clinical practice","volume":"56","author":"Lyngbakken","year":"2019","journal-title":"Crit Rev Clin Lab Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.12703\/r\/10-34","article-title":"Advancements in biomarkers for cardiovascular disease: diagnosis, prognosis, and therapy","volume":"10","author":"Wettersten","year":"2021","journal-title":"Fac Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","author":"Biomarkers Definitions Working","year":"2001","journal-title":"Clin Pharmacol Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/eurheartj\/eht024","article-title":"Biomarkers in atrial fibrillation: a clinical review","volume":"34","author":"Hijazi","year":"2013","journal-title":"Eur Heart J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.amjcard.2015.08.049","article-title":"Stroke risk factors beyond the CHA2DS2-VASc score: can we improve our identification of \u201cHigh Stroke Risk\u201d patients with atrial fibrillation?","volume":"116","author":"Szymanski","year":"2015","journal-title":"Am J Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1016\/j.jacc.2019.10.040","article-title":"Ischemic stroke risk in patients with nonvalvular atrial fibrillation: jacc review topic of the week","volume":"74","author":"Alkhouli","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2174\/0929867324666170718120651","article-title":"Biomarkers associated with stroke risk in atrial fibrillation","volume":"26","author":"Ioannou","year":"2019","journal-title":"Curr Med Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11886-019-1189-6","article-title":"Stroke risk in atrial fibrillation: beyond the CHA(2)DS(2)-VASc score","volume":"21","author":"Jagadish","year":"2019","journal-title":"Curr Cardiol Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/1358863X18819816","article-title":"Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: a clinical review","volume":"24","author":"Pallazola","year":"2019","journal-title":"Vasc Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1160\/TH12-03-0175","article-title":"The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study","volume":"107","author":"Olesen","year":"2012","journal-title":"Thromb Haemost."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1160\/TH15-02-0154","article-title":"Stroke risk in atrial fibrillation: do we anticoagulate CHADS2 or CHA2DS2-VASc \u22651, or higher?","volume":"113","author":"Olesen","year":"2015","journal-title":"Thromb Haemost."},{"key":"B25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3969\/j.issn.1671-5411.2013.03.004","article-title":"CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"10","author":"Chen","year":"2013","journal-title":"J Geriatr Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/pace.12445","article-title":"Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1","volume":"37","author":"Huang","year":"2014","journal-title":"Pacing Clin Electrophysiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.21037\/apm-20-297","article-title":"Optimized stratification of risk factors in and beyond the CHA 2 DS 2 -VASc score to differentiate the real thromboembolic risk in mainland China: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2020","journal-title":"Ann Palliative Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ahj.2015.10.028","article-title":"Racial\/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: insights from outcomes registry for better informed treatment for atrial fibrillation registry","volume":"174","author":"Golwala","year":"2016","journal-title":"Am Heart J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/STROKEAHA.118.021047","article-title":"Age threshold for ischemic stroke risk in atrial fibrillation","volume":"49","author":"Kim","year":"2018","journal-title":"Stroke."},{"key":"B31","doi-asserted-by":"publisher","first-page":"O1","DOI":"10.1093\/eurheartj\/suaa176","article-title":"Atrial fibrillation and stroke prevention: state of the art-epidemiology and pathophysiology: new risk factors, concepts and controversies","volume":"22","author":"Kodani","year":"2020","journal-title":"Europ Heart J Suppl."},{"key":"B32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.118.035411","article-title":"Refining prediction of atrial fibrillation-related stroke using the P(2)-CHA(2)DS(2)-VASc score","volume":"139","author":"Maheshwari","year":"2019","journal-title":"Circulation."},{"key":"B33","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ijcard.2016.07.145","article-title":"The value of urine albumin in predicting thromboembolic events for patients with non-valvular atrial fibrillation","volume":"221","author":"He","year":"2016","journal-title":"Int J Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jacc.2016.05.044","article-title":"Refining stroke prediction in atrial fibrillation patients by addition of african-american ethnicity to CHA2DS2-VASc score","volume":"68","author":"Kabra","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1253\/circj.CJ-18-0218","article-title":"Validation of conventional thromboembolic risk factors in a Korean atrial fibrillation population- suggestion for a novel scoring system, CHA(2)DS(2)-VAK","volume":"82","author":"Cha","year":"2018","journal-title":"Circ J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1161\/STROKEAHA.116.013880","article-title":"Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study","volume":"47","author":"Chao","year":"2016","journal-title":"Stroke."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e000250","DOI":"10.1161\/JAHA.113.000250","article-title":"A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J Am Heart Assoc."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e017157","DOI":"10.1136\/bmjopen-2017-017157","article-title":"Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation","volume":"7","author":"Fox","year":"2017","journal-title":"BMJ Open."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","article-title":"Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial","volume":"34","author":"Al-Khatib","year":"2013","journal-title":"Eur Heart J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur Heart J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e004267","DOI":"10.1161\/CIRCEP.116.004267","article-title":"Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)","volume":"10","author":"Link","year":"2017","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1161\/STROKEAHA.115.010947","article-title":"Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the fushimi atrial fibrillation registry","volume":"46","author":"Takabayashi","year":"2015","journal-title":"Stroke."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","article-title":"The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis","volume":"37","author":"Ganesan","year":"2016","journal-title":"Eur Heart J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1016\/j.jacc.2019.09.050","article-title":"Natural history of subclinical atrial fibrillation detected by implanted loop recorders","volume":"74","author":"Diederichsen","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00392-019-01493-z","article-title":"Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices","volume":"109","author":"Pastori","year":"2020","journal-title":"Clin Res Cardiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the MOde Selection Trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation."},{"key":"B50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.amjmed.2014.11.026","article-title":"Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry","volume":"128","author":"Boriani","year":"2015","journal-title":"Am J Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1016\/j.ijcard.2013.07.234","article-title":"A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study","volume":"168","author":"Potpara","year":"2013","journal-title":"Int J Cardiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e005595","DOI":"10.1161\/CIRCOUTCOMES.118.005595","article-title":"Atrial fibrillation burden signature and near-term prediction of stroke: a machine learning analysis","volume":"12","author":"Han","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"B55","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.hrthm.2020.10.017","article-title":"Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke","volume":"18","author":"Al-Gibbawi","year":"2021","journal-title":"Heart Rhythm."},{"key":"B56","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/europace\/euu267","article-title":"Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices","volume":"17","author":"Benezet-Mazuecos","year":"2015","journal-title":"Europace."},{"key":"B57","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5114\/aic.2018.78332","article-title":"Silent ischemic brain lesions detected by multi-slice computed tomography are associated with subclinical atrial fibrillation in patients with cardiac resynchronization therapy","volume":"14","author":"Icen","year":"2018","journal-title":"Postepy Kardiol Interwencyjnej."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.hrthm.2011.04.022","article-title":"Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS","volume":"8","author":"Daoud","year":"2011","journal-title":"Heart Rhythm."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/cvr\/cvab147","article-title":"Optimizing indices of AF susceptibility and burden to evaluate AF severity, risk and outcomes","volume":"116","author":"Boriani","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/hrt.82.5.547","article-title":"Left atrial appendage: structure, function, and role in thromboembolism","volume":"82","author":"Al-Saady","year":"1999","journal-title":"Heart."},{"key":"B62","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jacc.2012.04.032","article-title":"Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study","volume":"60","author":"Di Biase","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.4022\/jafib.2183","article-title":"Left atrial appendage morphology as a determinant for stroke risk assessment in atrial fibrillation patients: systematic review and meta-analysis","volume":"12","author":"Anan","year":"2019","journal-title":"J Atr Fibrillation."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.amjcard.2019.01.024","article-title":"Relation of left atrial appendage morphology determined by computed tomography to prior stroke or to increased risk of stroke in patients with atrial fibrillation","volume":"123","author":"Wu","year":"2019","journal-title":"Am J Cardiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/clc.23381","article-title":"The predictive value of a concise classification of left atrial appendage morphology to thrombosis in non-valvular atrial fibrillation patients","volume":"43","author":"He","year":"2020","journal-title":"Clin Cardiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcct.2019.04.005","article-title":"The left atrial appendage morphology is associated with embolic stroke subtypes using a simple classification system: a proof of concept study","volume":"14","author":"Yaghi","year":"2020","journal-title":"J Cardiovasc Comput Tomogr."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-021-02262-8.","article-title":"Statistical shape analysis of the left atrial appendage predicts stroke in atrial fibrillation","author":"Bieging","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"B68","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijcard.2015.04.033","article-title":"Relationship between left atrial appendage morphology and thrombus formation in patients with atrial fibrillation","volume":"188","author":"Zhao","year":"2015","journal-title":"Int J Cardiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.hrthm.2014.08.016","article-title":"Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation","volume":"11","author":"Nedios","year":"2014","journal-title":"Heart Rhythm."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0894-7317(99)70105-7","article-title":"Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)","volume":"12","author":"Goldman","year":"1999","journal-title":"J Am Soc Echocardiogr."},{"key":"B71","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.amjcard.2013.11.058","article-title":"Impact of increased orifice size and decreased flow velocity of left atrial appendage on stroke in nonvalvular atrial fibrillation","volume":"113","author":"Lee","year":"2014","journal-title":"Am J Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1016\/j.jacc.2017.10.063","article-title":"Structure and function of the left atrium and left atrial appendage: AF and stroke implications","volume":"70","author":"Delgado","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s11739-020-02303-5","article-title":"Can echocardiography improve the prediction of thromboembolic risk in atrial fibrillation? Evidences and perspectives","volume":"15","author":"Tufano","year":"2020","journal-title":"Intern Emerg Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"31042","DOI":"10.1038\/srep31042","article-title":"Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation","volume":"6","author":"Hamatani","year":"2016","journal-title":"Sci Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1161\/01.CIR.92.4.835","article-title":"Left atrial size and the risk of stroke and death. The Framingham Heart Study","volume":"92","author":"Benjamin","year":"1995","journal-title":"Circulation."},{"key":"B76","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00415-015-7957-3","article-title":"Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study","volume":"263","author":"Paciaroni","year":"2016","journal-title":"J Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jacc.2010.09.049","article-title":"Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation","volume":"57","author":"Daccarett","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jacc.2017.07.758","article-title":"Left atrial fibrosis and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation","volume":"70","author":"King","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/eurheartj\/ehx736","article-title":"Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry","volume":"39","author":"Leung","year":"2018","journal-title":"Eur Heart J."},{"key":"B80","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.echo.2011.01.016","article-title":"Association of decreased left atrial strain and strain rate with stroke in chronic atrial fibrillation","volume":"24","author":"Shih","year":"2011","journal-title":"J Am Soc Echocardiogr."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.echo.2012.09.004","article-title":"Left atrial strain is reduced in patients with atrial fibrillation, stroke or TIA, and low risk CHADS(2) scores","volume":"25","author":"Azemi","year":"2012","journal-title":"J Am Soc Echocardiogr."},{"key":"B82","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.echo.2014.03.010","article-title":"Left atrial strain provides incremental value for embolism risk stratification over CHA2DS2-VASc score and indicates prognostic impact in patients with atrial fibrillation","volume":"27","author":"Obokata","year":"2014","journal-title":"J Am Soc Echocardiogr."},{"key":"B83","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.amjcard.2015.05.060","article-title":"Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation","volume":"116","author":"Proietti","year":"2015","journal-title":"Am J Cardiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ehjqcco\/qcaa003","article-title":"Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: The Fushimi AF Registry","volume":"6","author":"Tezuka","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes."},{"key":"B85","doi-asserted-by":"publisher","first-page":"6","DOI":"10.7326\/0003-4819-116-1-6","article-title":"Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk","volume":"116","year":"1992","journal-title":"Ann Intern Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/archinte.158.12.1316","article-title":"Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials","volume":"158","author":"Atrial Fibrillation","year":"1998","journal-title":"Arch Intern Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jns.2008.04.006","article-title":"Tissue Doppler index, E\/E', and ischemic stroke in patients with atrial fibrillation and preserved left ventricular ejection fraction","volume":"271","author":"Lee","year":"2008","journal-title":"J Neurol Sci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"104900","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104900","article-title":"Is epicardial fat thickness associated with acute ischemic stroke in patients with atrial fibrillation?","volume":"29","author":"Cosansu","year":"2020","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1540-8175.2000.tb01153.x","article-title":"Spontaneous echo contrast: where there's smoke there's fire","volume":"17","author":"Black","year":"2000","journal-title":"Echocardiography."},{"key":"B90","doi-asserted-by":"publisher","first-page":"27650","DOI":"10.1038\/srep27650","article-title":"Intensity of left atrial spontaneous echo contrast as a correlate for stroke risk stratification in patients with nonvalvular atrial fibrillation","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci Rep."},{"key":"B91","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.genhosppsych.2014.07.001","article-title":"Electrocardiography changes in bipolar patients during long-term lithium monotherapy","volume":"36","author":"Altinbas","year":"2014","journal-title":"Gen Hosp Psychiatry."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1161\/STROKEAHA.117.017293","article-title":"P-wave indices and risk of ischemic stroke: a systematic review and meta-analysis","volume":"48","author":"He","year":"2017","journal-title":"Stroke."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e12632","DOI":"10.1111\/anec.12632","article-title":"Advanced interatrial block is a surrogate for left atrial strain reduction which predicts atrial fibrillation and stroke","volume":"24","author":"Lacalzada-Almeida","year":"2019","journal-title":"Ann Noninvasive Electrocardiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jelectrocard.2019.11.050","article-title":"Advanced interatrial block: a predictor of covert atrial fibrillation in embolic stroke of undetermined source","volume":"58","author":"Mendieta","year":"2020","journal-title":"J Electrocardiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/ehjci\/jev354","article-title":"EACVI\/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation","volume":"17","author":"Donal","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e0210945","DOI":"10.1371\/journal.pone.0210945","article-title":"The association of CHA2DS2-VASc score and carotid plaque in patients with non-valvular atrial fibrillation","volume":"14","author":"Shang","year":"2019","journal-title":"PLoS ONE."},{"key":"B97","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11883-019-0808-4","article-title":"Carotid atherosclerosis in patients with atrial fibrillation","volume":"21","author":"Wang","year":"2019","journal-title":"Curr Atheroscler Rep."},{"key":"B98","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijcard.2017.01.001","article-title":"Carotid plaque detection improves the predictive value of CHA(2)DS(2)-VASc score in patients with non-valvular atrial fibrillation: the ARAPACIS Study","volume":"231","author":"Basili","year":"2017","journal-title":"Int J Cardiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3904\/kjim.2019.099","article-title":"Impact of carotid atherosclerosis in CHA2DS2-VASc-based risk score on predicting ischemic stroke in patients with atrial fibrillation","volume":"36","author":"Cho","year":"2021","journal-title":"Korean J Intern Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/STROKEAHA.116.013133","article-title":"Carotid atherosclerosis and stroke in atrial fibrillation: the atherosclerosis risk in communities study","volume":"47","author":"Bekwelem","year":"2016","journal-title":"Stroke."},{"key":"B101","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3760\/cma.j.cn112138-20190425-00324","article-title":"[The association between carotid atherosclerosis and ischemic stroke in patients with nonvalvular atrial fibrillation]","volume":"59","author":"Shang","year":"2020","journal-title":"Zhonghua Nei Ke Za Zhi."},{"key":"B102","doi-asserted-by":"publisher","first-page":"117444","DOI":"10.1016\/j.jns.2021.117444","article-title":"Stroke risk associated with carotid and aortic atherosclerosis in patients with atrial fibrillation: a systematic review","volume":"425","author":"Noubiap","year":"2021","journal-title":"J Neurol Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijcard.2014.10.039","article-title":"Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients","volume":"179","author":"Perri","year":"2015","journal-title":"Int J Cardiol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"589684","DOI":"10.3389\/fneur.2020.589684","article-title":"Statin effects in atrial fibrillation-related stroke: a systematic review and meta-analysis","volume":"11","author":"Eun","year":"2020","journal-title":"Front Neurol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2018035","DOI":"10.1155\/2020\/2018035","article-title":"The biomarkers for acute myocardial infarction and heart failure","volume":"2020","author":"Wang","year":"2020","journal-title":"BioMed Res Int."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/ijms20081820","article-title":"BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine","volume":"20","author":"Cao","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00380-010-0084-2","article-title":"Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation","volume":"26","author":"Sadanaga","year":"2011","journal-title":"Heart Vessels."},{"key":"B108","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2009.02.374","article-title":"Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation: a brain natriuretic peptide study","volume":"281","author":"Shibazaki","year":"2009","journal-title":"J Neurol Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/hs0402.105657","article-title":"High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation","volume":"33","author":"Shimizu","year":"2002","journal-title":"Stroke."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.jacc.2012.11.082","article-title":"N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)","volume":"61","author":"Hijazi","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","article-title":"Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy","volume":"125","author":"Hijazi","year":"2012","journal-title":"Circulation."},{"key":"B112","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jamacardio.2016.3311","article-title":"Cardiovascular biomarker score and clinical outcomes in patients with atrial fibrillation: a subanalysis of the ENGAGE AF-TIMI 48 randomized clinical trial","volume":"1","author":"Ruff","year":"2016","journal-title":"JAMA Cardiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1161\/STROKEAHA.113.003338","article-title":"Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation","volume":"45","author":"Rold\u00e1n","year":"2014","journal-title":"Stroke."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1253\/circj.CJ-17-1085","article-title":"Impact of B-type natriuretic peptide level on risk stratification of thromboembolism and death in patients with nonvalvular atrial fibrillation- The Hokuriku-Plus AF registry","volume":"82","author":"Hayashi","year":"2018","journal-title":"Circ J."},{"key":"B115","first-page":"3","article-title":"Assessment of cardiac biomarkers (troponin, B-type natriuretic peptide, and D-dimer) in patients with non-valvular atrial fibrillation and stroke","volume":"13","author":"Paulin","year":"2019","journal-title":"Int J Health Sci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/heartjnl-2020-317735","article-title":"Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure","volume":"107","author":"Hamatani","year":"2020","journal-title":"Heart"},{"key":"B117","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clineuro.2014.09.028","article-title":"Brain natriuretic peptide level on admission predicts recurrent stroke after discharge in stroke survivors with atrial fibrillation","volume":"127","author":"Shibazaki","year":"2014","journal-title":"Clin Neurol Neurosurg."},{"key":"B118","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2019.03.031","article-title":"Accurate etiology diagnosis in patients with stroke and atrial fibrillation: a role for brain natriuretic peptide","volume":"400","author":"Sakamoto","year":"2019","journal-title":"J Neurol Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1253\/circj.CJ-17-1238","article-title":"High cardiac troponin I is associated with transesophageal echocardiographic risk of thromboembolism and ischemic stroke events in non-valvular atrial fibrillation patients","volume":"82","author":"Tanaka","year":"2018","journal-title":"Circ J."},{"key":"B120","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jacc.2013.07.093","article-title":"High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin","volume":"63","author":"Hijazi","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/j.1538-7836.2012.04812.x","article-title":"High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation","volume":"10","author":"Rold\u00e1n","year":"2012","journal-title":"J Thromb Haemost."},{"key":"B122","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1161\/CIRCULATIONAHA.118.038312","article-title":"Performance of the ABC scores for assessing the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48","volume":"139","author":"Berg","year":"2019","journal-title":"Circulation."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/STROKEAHA.119.028323","article-title":"Association between high-sensitivity cardiac troponin and risk of stroke in 96 702 individuals: a meta-analysis","volume":"51","author":"Broersen","year":"2020","journal-title":"Stroke."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/eurheartj\/ehab141","article-title":"Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial","volume":"42","author":"Oyama","year":"2021","journal-title":"Eur Heart J."},{"key":"B125","doi-asserted-by":"publisher","first-page":"7089493","DOI":"10.1155\/2017\/7089493","article-title":"Red blood cell distribution width: a novel predictive indicator for cardiovascular and cerebrovascular diseases","volume":"2017","author":"Li","year":"2017","journal-title":"Dis Markers."},{"key":"B126","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.ijcard.2016.11.255","article-title":"Relation of red blood cell distribution width with CHADS(2) and CHA(2)DS(2)-VASc score in Chinese patients with non-valvular atrial fibrillation","volume":"228","author":"Liu","year":"2017","journal-title":"Int J Cardiol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"408","DOI":"10.11909\/j.issn.1671-5411.2018.06.007","article-title":"Predictive value of red cell distribution width on left atrial thrombus or left atrial spontaneous echo contrast in patients with non-valvular atrial fibrillation","volume":"15","author":"Zhan","year":"2018","journal-title":"J Geriatr Cardiol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejim.2017.07.028","article-title":"Association between red cell distribution width and thromboembolic events in patients with atrial fibrillation","volume":"46","author":"Cha","year":"2017","journal-title":"Eur J Intern Med."},{"key":"B129","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.amjmed.2014.09.020","article-title":"The association between red cell distribution width and stroke in patients with atrial fibrillation","volume":"128","author":"Saliba","year":"2015","journal-title":"Am J Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.amjcard.2010.09.039","article-title":"Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure","volume":"107","author":"Uthamalingam","year":"2011","journal-title":"Am J Cardiol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/clc.22869","article-title":"Use of neutrophil-lymphocyte ratio for risk stratification and relationship with time in therapeutic range in patients with nonvalvular atrial fibrillation: a pilot study","volume":"41","author":"Cosansu","year":"2018","journal-title":"Clin Cardiol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2012.09.032","article-title":"Neutrophil\/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation","volume":"324","author":"Erta\u015f","year":"2013","journal-title":"J Neurol Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1111\/jth.13006","article-title":"Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study","volume":"13","author":"Saliba","year":"2015","journal-title":"J Thromb Haemost."},{"key":"B134","doi-asserted-by":"publisher","first-page":"9213074","DOI":"10.1155\/2019\/9213074","article-title":"Mean Platelet Volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions","volume":"2019","author":"Korniluk","year":"2019","journal-title":"Mediators Inflamm."},{"key":"B135","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3109\/09537104.2011.560306","article-title":"Stroke prediction using mean platelet volume in patients with atrial fibrillation","volume":"22","author":"Ha","year":"2011","journal-title":"Platelets."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/clc.22759","article-title":"Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation","volume":"40","author":"Choi","year":"2017","journal-title":"Clin Cardiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.7754\/Clin.Lab.2018.180543","article-title":"Mean platelet volume in patients with acute ischemic stroke with nonvalvular atrial fibrillation","volume":"64","author":"Gul","year":"2018","journal-title":"Clin Lab."},{"key":"B138","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12872-020-01525-x","article-title":"Mean platelet volume: a new predictor of ischaemic stroke risk in patients with nonvalvular atrial fibrillation","volume":"20","author":"Zheng","year":"2020","journal-title":"BMC Cardiovasc Disord."},{"key":"B139","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/1358863X18755927","article-title":"Hypercoagulable states in arterial and venous thrombosis: when, how, and who to test?","volume":"23","author":"Carroll","year":"2018","journal-title":"Vasc Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1373\/clinchem.2011.166249","article-title":"D-dimer testing in laboratory practice","volume":"57","author":"Tripodi","year":"2011","journal-title":"Clin Chem."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2169\/internalmedicine.55.6087","article-title":"Serum D-dimer levels are proportionally associated with left atrial enlargement in patients with an acute ischemic stroke due to non-valvular atrial fibrillation","volume":"55","author":"Kim","year":"2016","journal-title":"Intern Med."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/jth.12638","article-title":"D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation\u2013observations from the ARISTOTLE trial","volume":"12","author":"Christersson","year":"2014","journal-title":"J Thromb Haemost."},{"key":"B143","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1055\/s-0037-1615530","article-title":"D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy","volume":"115","author":"Siegbahn","year":"2016","journal-title":"Thromb Haemost."},{"key":"B144","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijcard.2005.05.049","article-title":"D-dimer level influences thromboembolic events in patients with atrial fibrillation","volume":"109","author":"Nozawa","year":"2006","journal-title":"Int J Cardiol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.thromres.2011.08.014","article-title":"A multicentric prospective study in usual care: D-dimer and cardiovascular events in patients with atrial fibrillation","volume":"129","author":"Mah\u00e9","year":"2012","journal-title":"Thromb Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000457808","article-title":"Brain natriuretic peptide is a powerful predictor of outcome in stroke patients with atrial fibrillation","volume":"7","author":"Maruyama","year":"2017","journal-title":"Cerebrovasc Dis Extra."},{"key":"B147","doi-asserted-by":"publisher","first-page":"e12622","DOI":"10.1097\/MD.0000000000012622","article-title":"The association of high D-dimer level with high risk of ischemic stroke in nonvalvular atrial fibrillation patients: a retrospective study","volume":"97","author":"You","year":"2018","journal-title":"Medicine."},{"key":"B148","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem."},{"key":"B149","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/hrt.73.6.527","article-title":"Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment","volume":"73","author":"Lip","year":"1995","journal-title":"Br Heart J."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1161\/01.CIR.0000033220.97592.9A","article-title":"Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors","volume":"106","author":"Conway","year":"2002","journal-title":"Circulation."},{"key":"B151","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","article-title":"Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation","volume":"107","author":"Conway","year":"2003","journal-title":"Circulation."},{"key":"B152","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1042\/CS20080372","article-title":"Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF)","volume":"116","author":"Pinto","year":"2009","journal-title":"Clin Sci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.acvd.2017.08.004","article-title":"Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?","volume":"111","author":"Ancedy","year":"2018","journal-title":"Arch Cardiovasc Dis."},{"key":"B154","doi-asserted-by":"publisher","first-page":"97","DOI":"10.12659\/MSMBR.902557","article-title":"Predictive role of coagulation, fibrinolytic, and endothelial markers in patients with atrial fibrillation, stroke, and thromboembolism: a meta-analysis, meta-regression, systematic review","volume":"23","author":"Weymann","year":"2017","journal-title":"Med Sci Monit Basic Res."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.17219\/acem\/104557","article-title":"CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation","volume":"28","author":"Semczuk-Kaczmarek","year":"2019","journal-title":"Adv Clin Exp Med."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1046\/j.1538-7836.2003.0468d.x","article-title":"Fibrinogen as predictor of ischemic stroke in patients with non-valvular atrial fibrillation","volume":"1","author":"Di Lecce","year":"2003","journal-title":"J Thromb Haemost."},{"key":"B157","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.06.027","article-title":"Association between fibrinogen and leukoaraiosis in patients with ischemic stroke and atrial fibrillation","volume":"26","author":"Wei","year":"2017","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.amjcard.2016.12.031","article-title":"Relation of low-density lipoprotein cholesterol to ischemic stroke in patients with nonvalvular atrial fibrillation","volume":"119","author":"Qi","year":"2017","journal-title":"Am J Cardiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.amjmed.2020.08.035","article-title":"LDL cholesterol and ischemic stroke in patients with nonvalvular atrial fibrillation","volume":"134","author":"Omelchenko","year":"2020","journal-title":"Am J Med"},{"key":"B160","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/STROKEAHA.117.017343","article-title":"Statin adherence is associated with reduced recurrent stroke risk in patients with or without atrial fibrillation","volume":"48","author":"Flint","year":"2017","journal-title":"Stroke."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/STROKEAHA.111.646778","article-title":"Total and high-density lipoprotein cholesterol and stroke risk","volume":"43","author":"Zhang","year":"2012","journal-title":"Stroke."},{"key":"B162","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12944-020-01392-7","article-title":"LDL-C\/HDL-C is associated with ischaemic stroke in patients with non-valvular atrial fibrillation: a case-control study","volume":"19","author":"Zhang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"B163","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2169\/internalmedicine.37.995","article-title":"Increased plasma lipoprotein(a) level in cardioembolic stroke with non-valvular atrial fibrillation","volume":"37","author":"Okura","year":"1998","journal-title":"Intern Med."},{"key":"B164","doi-asserted-by":"publisher","first-page":"e007372","DOI":"10.1161\/JAHA.117.007372","article-title":"Associations of lipoprotein(a) Levels with incident atrial fibrillation and ischemic stroke: the ARIC (Atherosclerosis Risk in Communities) study","volume":"6","author":"Aronis","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11883-017-0639-0","article-title":"Influence of inflammation and atherosclerosis in atrial fibrillation","volume":"19","author":"da Silva","year":"2017","journal-title":"Curr Atheroscler Rep."},{"key":"B166","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2143\/AC.61.5.2017764","article-title":"Left atrial function in patients with a high C-reactive protein level and paroxysmal atrial fibrillation","volume":"61","author":"Dernellis","year":"2006","journal-title":"Acta Cardiol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1161\/01.STR.0000260090.90508.3e","article-title":"High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis","volume":"38","author":"Lip","year":"2007","journal-title":"Stroke."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ahj.2015.09.018","article-title":"Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation","volume":"170","author":"Aulin","year":"2015","journal-title":"Am Heart J."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1111\/1440-1681.13374","article-title":"Serum uric acid and incident atrial fibrillation: a systematic review and dose-response meta-analysis","volume":"47","author":"Zhang","year":"2020","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cjca.2014.06.009","article-title":"Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation","volume":"30","author":"Tang","year":"2014","journal-title":"Can J Cardiol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1536\/ihj.16-444","article-title":"The refinement of risk stratification for atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation","volume":"58","author":"Ning","year":"2017","journal-title":"Int Heart J."},{"key":"B172","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijcard.2018.01.080","article-title":"Predictive effect of hyperuricemia on left atrial stasis in non-valvular atrial fibrillation patients","volume":"258","author":"Liu","year":"2018","journal-title":"Int J Cardiol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"604795","DOI":"10.3389\/fcvm.2020.604795","article-title":"A study of cardiogenic stroke risk in non-valvular atrial fibrillation patients","volume":"7","author":"Song","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1253\/circj.CJ-13-1385","article-title":"Hyperuricemia and transesophageal echocardiographic thromboembolic risk in patients with atrial fibrillation at clinically low-intermediate risk","volume":"78","author":"Numa","year":"2014","journal-title":"Circ J."},{"key":"B175","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijcard.2013.11.011","article-title":"Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation\u2013could it refine clinical risk stratification in AF?","volume":"170","author":"Chao","year":"2014","journal-title":"Int J Cardiol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/09537104.2017.1293805","article-title":"Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation","volume":"29","author":"Tarnowski","year":"2018","journal-title":"Platelets."},{"key":"B177","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/europace\/eum284","article-title":"Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation","volume":"10","author":"Duygu","year":"2008","journal-title":"Europace."},{"key":"B178","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1161\/ATVBAHA.107.152777","article-title":"Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation","volume":"27","author":"Ferro","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/01.STR.0000060202.63475.BA","article-title":"Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation","volume":"34","author":"Ay","year":"2003","journal-title":"Stroke."},{"key":"B180","first-page":"1205","article-title":"The association between hyperhomocysteinemia and ischemic stroke in patients with non-valvular atrial fibrillation","volume":"90","author":"Loffredo","year":"2005","journal-title":"Haematologica."},{"key":"B181","doi-asserted-by":"publisher","first-page":"743","DOI":"10.11909\/j.issn.1671-5411.2017.12.004","article-title":"Effect of advanced age on plasma homocysteine levels and its association with ischemic stroke in non-valvular atrial fibrillation","volume":"14","author":"Yao","year":"2017","journal-title":"J Geriatr Cardiol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.numecd.2020.11.007","article-title":"Association of adipocytokines serum levels with left atrial thrombus formation in atrial fibrillation patients on oral anticoagulation (Alert) - a cross-sectional study","volume":"31","author":"Blessberger","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B183","doi-asserted-by":"publisher","first-page":"908901","DOI":"10.1155\/2014\/908901","article-title":"Total adiponectin is inversely associated with platelet activation and CHA2DS2-VASc score in anticoagulated patients with atrial fibrillation","volume":"2014","author":"Carnevale","year":"2014","journal-title":"Mediators Inflamm."},{"key":"B184","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/eci.12028","article-title":"The prognostic role of the adiponectin levels in atrial fibrillation","volume":"43","author":"Hern\u00e1ndez-Romero","year":"2013","journal-title":"Eur J Clin Invest."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00424-020-02459-1","article-title":"GDF15, an update of the physiological and pathological roles it plays: a review","volume":"472","author":"Assadi","year":"2020","journal-title":"Pflugers Arch."},{"key":"B186","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/clc.22844","article-title":"Growth differentiation factor 15 is associated with left atrial\/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation","volume":"41","author":"Hu","year":"2018","journal-title":"Clin Cardiol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1161\/CIRCULATIONAHA.114.011204","article-title":"Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial","volume":"130","author":"Wallentin","year":"2014","journal-title":"Circulation."},{"key":"B188","doi-asserted-by":"publisher","first-page":"e22246","DOI":"10.1002\/jbt.22246","article-title":"Trimethylamine N-oxide as a risk marker for ischemic stroke in patients with atrial fibrillation","volume":"33","author":"Liang","year":"2019","journal-title":"J Biochem Mol Toxicol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijcard.2020.03.053","article-title":"Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: a two-sample Mendelian randomization study","volume":"313","author":"Yuan","year":"2020","journal-title":"Int J Cardiol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.cjca.2014.12.002","article-title":"Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis","volume":"31","author":"Wu","year":"2015","journal-title":"Can J Cardiol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.hlc.2018.05.094","article-title":"Circulating Galectin-3 is associated with left atrial appendage remodelling and thrombus formation in patients with atrial fibrillation","volume":"28","author":"Tang","year":"2019","journal-title":"Heart Lung Circ."},{"key":"B192","doi-asserted-by":"publisher","first-page":"e0189936","DOI":"10.1371\/journal.pone.0189936","article-title":"Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study","volume":"13","author":"Begg","year":"2018","journal-title":"PLoS ONE."},{"key":"B193","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCRESAHA.120.316575","article-title":"Genetics of atrial fibrillation in 2020: GWAS. genome sequencing, polygenic risk, and beyond","volume":"127","author":"Roselli","year":"2020","journal-title":"Circ Res."},{"key":"B194","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1161\/STROKEAHA.114.006072","article-title":"Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke","volume":"45","author":"Tada","year":"2014","journal-title":"Stroke."},{"key":"B195","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1212\/NXG.0000000000000293","article-title":"Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes","volume":"4","author":"Pulit","year":"2018","journal-title":"Neurol Genet."},{"key":"B196","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2217\/pgs-2019-0054","article-title":"GWAS contribution to atrial fibrillation and atrial fibrillation-related stroke: pathophysiological implications","volume":"20","author":"Cruz","year":"2019","journal-title":"Pharmacogenomics."},{"key":"B197","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/jcm8030332","article-title":"Genome-Wide copy number variation association study of atrial fibrillation related thromboembolic stroke","volume":"8","author":"Hsieh","year":"2019","journal-title":"J Clin Med."},{"key":"B198","doi-asserted-by":"publisher","first-page":"e003168","DOI":"10.1161\/CIRCGEN.120.003168","article-title":"Combining clinical and polygenic risk improves stroke prediction among individuals with atrial fibrillation","volume":"14","author":"O'Sullivan","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"B199","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12967-019-1790-x","article-title":"Bioinformatic gene analysis for potential biomarkers and therapeutic targets of atrial fibrillation-related stroke","volume":"17","author":"Zou","year":"2019","journal-title":"J Transl Med."},{"key":"B200","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fneur.2020.00184","article-title":"Identification of co-expressed genes between atrial fibrillation and stroke","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Neurol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.3390\/ijms21072444","article-title":"Exploratory analysis of circulating mirna signatures in atrial fibrillation patients determining potential biomarkers to support decision-making in anticoagulation and catheter ablation","volume":"21","author":"Kiyosawa","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B202","doi-asserted-by":"publisher","first-page":"e23352","DOI":"10.1002\/jcla.23352","article-title":"The correlation of serum long non-coding RNA ANRIL with risk factors, functional outcome, and prognosis in atrial fibrillation patients with ischemic stroke","volume":"34","author":"Zeng","year":"2020","journal-title":"J Clin Lab Anal."},{"key":"B203","doi-asserted-by":"publisher","first-page":"e018984","DOI":"10.1161\/JAHA.120.018984","article-title":"Screening of multiple biomarkers associated with ischemic stroke in atrial fibrillation","volume":"9","author":"Hijazi","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B204","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/07853890.2017.1378429","article-title":"Enhancing the \u201creal world\u201d prediction of cardiovascular events and major bleeding with the CHA(2)DS(2)-VASc and HAS-BLED scores using multiple biomarkers","volume":"50","author":"Rold\u00e1n","year":"2018","journal-title":"Ann Med."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1161\/STROKEAHA.118.024305","article-title":"Refining stroke and bleeding prediction in atrial fibrillation by adding consecutive biomarkers to clinical risk scores","volume":"50","author":"Rivera-Caravaca","year":"2019","journal-title":"Stroke."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.682538\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T16:11:43Z","timestamp":1625155903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.682538\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":205,"alternative-id":["10.3389\/fcvm.2021.682538"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.682538","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"article-number":"682538"}}